Patents Assigned to Du Pont Mereck Pharmaceutical Company
  • Oral anticoagulant/platelet inhibitor low dose formulation
    Patent number: 5041430
    Abstract: There are disclosed combination products useful for the treatment and/or prevention of a first or recurrent myocardial infarction or a first or recurrent stroke. Said combination products comprise low doses of an oral anticoagulant, preferably warfarin and platelet inhibiting agents, including non-steroidal antiinflammatory agents and preferrably aspirin.
    Type: Grant
    Filed: September 18, 1989
    Date of Patent: August 20, 1991
    Assignee: Du Pont Mereck Pharmaceutical Company
    Inventors: William J. Addicks, Joseph A. Mollica, Gary H. Slatko